Abstract
Radioiodine uptake is not commonly seen by the thymus gland. On the contrary, the gland is slowly replaced by fat after puberty. Herein, we present 2 patients with papillary thyroid carcinoma, follicular variant, and cervical lymph node involvement. After total/near-total thyroidectomy, the patients received 131I for ablation therapy. On posttreatment radioiodine scintigraphy, mediastinal 131I uptake was noted that finally was histologically/anatomically diagnosed as thymus gland uptake. It should be borne in mind as a potential cause of false-positive whole-body 131I scintigraphy.
INTRODUCTION
Differentiated thyroid cancer (DTC) is an unusual tumor with a good prognosis when adequately treated, but can recur locally or with distant metastases even decades after initial therapy.1 The mainstay of treatment is total or near-total thyroidectomy. Radioiodine (131I) therapy is often used as an adjunct to surgery because it has been reported to improve survival rate.2,3 The whole body scan (WBS) with 123I or 131I is the gold standard imaging for the detection of thyroid remnant and regional or distant metastases, thus being routinely used for evaluation before and after radioiodine therapy.4–7 However, false-positive WBS may occur because of radioiodine uptake by normal or pathological tissues that are not related to the thyroid tissue. This could lead to unsuitable therapy, such as unnecessary surgery or administration of 131I. There are many normal tissues that commonly accumulate iodine, such as breasts, salivary glands, gastrointestinal, and urinary systems.4,5 In addition, pathological uptake has been reported in neoplastic diseases or pulmonary inflammatory, sinusitis, pericardial effusions, esophagus pathologies, urinary tract diseases, ovarian cysts or tumors, and traumatic lesions.5–8 Radioiodine uptake by normal thymus is an uncommon reason of false-positive WBS that might be considered as lung or mediastinal nodes metastases.4,9–12 It should be borne in mind to recognize this condition in order to facilitate distinction between this normal variant and metastases. We present two patients with DTC, who underwent total thyroidectomy and 131I therapy that had 131I concentrate in the mediastinum during the follow-up, and provide a review of the latest insights.
CASE 1
A 33-year-old woman underwent total thyroidectomy and bilateral neck dissection with histopathological diagnosis of papillary thyroid carcinoma, follicular variant, and cervical lymph node involvement. She received 5550 MBq (150 mCi) of 131I for ablation (first 131I therapy). First posttreatment scan was only positive in the superior mediastinum with no evidence of cervical region uptake (Figure 1A). A computed tomography (CT) scan showed soft tissue attenuation in the mediastinum with possibility of lymph node metastasis (Figure 1B). Surgical excision was performed that subsequently showed thymic tissue.
FIGURE 1.

(A) Upper mediastinal uptake with no thyroid activity flowing first treatment is noted. (B) Soft tissue attenuation mass reveals in the upper mediastinum on CT scan, with histopathologic verification of thymic tissue.
CASE 2
A14-year-old girl presented with a history of papillary thyroid carcinoma for which she underwent near-total thyroidectomy with left-side lymph node dissection and received ablative dose of 4070 MBq (110 mCi) of 131I 1 year ago. In first posttreatment WBS, thyroid remnant tissue with no evidence of regional or distant metastasis was noted. Diagnostic WBS was performed 12 months after ablative therapy and was in favor of lymph node metastasis in the left-side of the neck. The patient submitted to neck dissection and then received 4440 MBq (120 mCi) of 131I. Second posttreatment WBS was only positive in the superior mediastinum with no evidence of cervical region uptake and the uptake in the mediastinum appeared to increase from 2 to 14 days (Figure 2A, B). A CT scan showed the presence of a heterogeneous mass, bell shaped in the mediastinum, suggestive of thymus (Figure 2C), with no evidence of metastatic disease. Because the scans of the patients were anonymous and no experimental intervention was done for the patients, ethical approval was not necessary.
FIGURE 2.

(A) Iodine-131 WBS 48 hours after second treatment reveals faint uptake in the anterior mediastinum. (B) 131I WBS 14 days later reveals intense uptake in the same region. (C) Soft tissue attenuation mass(thymus) reveals in the upper mediastinum on CT scan.
DISCUSSION
Radioiodine is very valuable for the diagnosis and treatment of both benign and malignant residual thyroid tissue in patients who have submitted to thyroidectomy for DTC.2 Cognizance of false-positive findings in the diagnostic or posttreatment WBS in patients with DTC is essential to avoid unnecessary treatment. False-positive findings in the chest may be because of inflammatory processes, ectopic thyroid tissue, neoplasms of nonthyroidal origin, body secretions, and pathological transudates.13 Thymic uptake of radioiodine is one of the possible causes that can be either because of the misinterpretation of metastatic mediastinal spread or because of an intrathymic ectopic thyroid tissue,4,9–13 thyroidal metastases to the thymus,14 residual normal thymus,2,11,12 or thymic hyperplasia.6,9–11 The mechanism of iodine uptake by the thymus is not yet fully understood. Vermiglio et al15 considered the possibility of iodine accumulation in the Hassal's bodies present in the thymic tissue because of the similarity to the follicular cells of the thyroid. Spitzweg et al16 showed the presence of the human Na+/I symporter (hNIS) in extra thyroidal tissue, including the thymus gland, with diminished capacity to transport and concentrate iodine, compared with the thyroid gland, which could explain why higher activities, late scanning, after the ablation of the thyroid remnant, and absence of metastatic spread (loss of tissue with higher hNIS expression than the thymus), increase the possibility of visualization of the thymic tissue after administration of radioiodine.9,13 In the present case report, two patients presented thymic uptake in the posttherapy WBS. Surgical removal of mediastinal mass in 1 patient was done with histopathologic verification of thymic tissue, without any evidence of thyroidal or neoplastic cells. Another patient, without histological confirmation, had a CT scan indicative of thymus tissue and is in periodic monitoring. The association between thymic hyperplasia and benign thyroidal disease, especially Graves disease, is well known. The identity of Thyroid Stimulating Hormone (TSH) receptors in the human thymic tissue has also been reported.17–20 Niendorf et al21 for the first time showed relationship between thymic hyperplasia and DTC. The mechanism of this association is not thought to be similar to the thymic hyperplasia demonstrated after chemotherapy or after stress conditions or acute infections, when hyperplasia happen because of an immunological reaction.22 It seems that l-thyroxin hormone therapy in supraphysiological doses is responsible for the thymic hyperplasia in patients with thyroid carcinoma.21 Heath et al,23 with the technique of reverse transcription and polymerase chain reaction from analyses of mRNA, showed the thymic expression of thyroglobulin (Tg) in embryonic mice and adult rats. Sospedra et al24 reported transcription of Tg in 4 of 12 specimens of human thymus, and Gotter et al25 found the existence of Tg expression in medullary epithelial cells of human thymus. Mello et al4 considered the possibility of the thymic tissue as a source of benign production of Tg, and suggested randomized studies to evaluate whether the Tg generation by the thymus is actually efficient and whether it could be stimulated by TSH. Michigishi et al9 considered reliable criteria to distinguish malignant from benign mediastinal uptake. Thymic uptake that visualized only by higher activities on posttreatment scintigraphy becomes more intense with repeated 131I treatment, low serum Tg levels, younger age (<45 years) and a hyperplastic thymus indicative of nonmetastatic radioiodine accumulation. It should be born in mind that beside thymic uptake, radioiodine accumulation in the midline of the thorax may be because of various causes, for example tracer accumulation in the esophagus, hiatal hernia, and aspiration of radioactive saliva in the tracheobronchial tree.13,26
Footnotes
Abbreviations: DTC = differentiated thyroid cancer, Tg = thyroglobulin, WBS = whole body scan.
The authors have no funding and conflicts of interest to disclose..
REFERENCES
- 1.Tharp K, Israel O, Hausmann J, et al. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 2004; 31:1435–1442. [DOI] [PubMed] [Google Scholar]
- 2.Davidson J, McDougall IR. How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans? Eur J Nucl Med 2000; 27:425–430. [DOI] [PubMed] [Google Scholar]
- 3.Wilson LM, Barrington SF, Morrison ID, et al. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nuc Med 1998; 25:622–628. [DOI] [PubMed] [Google Scholar]
- 4.Mello ME, Flamini RC, Corbo R, et al. Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases. Arq Bras Endocrinol Metabol 2009; 53:874–879. [DOI] [PubMed] [Google Scholar]
- 5.Rudoni S, Toubeau M, Mansuy S, et al. False positive scintigraphic images in the surveillance of differentiated thyroid cancers. Ann Endocrinol 1997; 58:399–407. [PubMed] [Google Scholar]
- 6.Salvatori M, Saletnich I, Rufini V, et al. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma. Clin Nucl Med 1997; 22:380–384. [DOI] [PubMed] [Google Scholar]
- 7.Ong SC, Eng DNC, Sundram FX, et al. A novel case of false-positive I-131 whole-body scan in thyroid carcinoma caused by subdural hematoma. Clin Nucl Med 2004; 29:164–166. [DOI] [PubMed] [Google Scholar]
- 8.Lungo M, Tenenbaum F, Chaumerliac P, et al. Ovarian endometriosis cyst with iodine 131 uptake: first case of false positive in the follow up for differentiated thyroid carcinoma. Ann Endocrinol 2000; 61:147–150. [PubMed] [Google Scholar]
- 9.Michigishi T, Mizukami Y, Shuke N, et al. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med 1993; 20:75–79. [DOI] [PubMed] [Google Scholar]
- 10.Connolly LP, Connolly SA. Thymic uptake of radiopharmaceuticals. Clin Nucl Med 2003; 28:648–651. [DOI] [PubMed] [Google Scholar]
- 11.Lee SH, Kwon HS, Yoo IR, et al. False-positive iodine uptake in thymic hyperplasia on diagnostic I-123 whole-body scan after total thyroidectomy. Clin Nucl Med 2007; 32:154–155. [DOI] [PubMed] [Google Scholar]
- 12.Montella L, Caraglia M, Abbruzzese A, et al. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer. Monaldi Arch Chest Dis 2005; 63:114–117. [DOI] [PubMed] [Google Scholar]
- 13.Meller J, Becker W. The human sodium-iodine symporter (NIS) as a key for specific thymic iodine-131 uptake. Eur J Nucl Med 2000; 27:473–474. [DOI] [PubMed] [Google Scholar]
- 14.Nam MS, Chu YC, Choe WS, et al. Metastatic follicular thyroid carcinoma to the thymus in a 35-year-old woman. Yonsei Med J 2002; 43:665–669. [DOI] [PubMed] [Google Scholar]
- 15.Vermiglio F, Baudin E, Travagli JP, et al. Iodine concentration by the thymus in thyroid carcinoma. J Nucl Med 1996; 37:1830–1831. [PubMed] [Google Scholar]
- 16.Spitzweg C, Joba W, Eisenmenger W, et al. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 1998; 83:1746–1751. [DOI] [PubMed] [Google Scholar]
- 17.Murakami M, Hosoi Y, Negishi T, et al. Thymic hyperplasia in patients with Graves’ disease. Identification of thyrotropin receptors in human thymus. J Clin Invest 1996; 98:2228–2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kirkeby K, Pont A. Thymic hyperplasia in a patient with Graves’ disease. J Clin Endocrinol Metab 2006; 91:1. [DOI] [PubMed] [Google Scholar]
- 19.Brinkane A, Ounadi-Corbille W, Bellamy J, et al. Hyperplasia of the thymus in Graves’ disease. A case report. Revue Pneumol Clin 2004; 60:239–241. [DOI] [PubMed] [Google Scholar]
- 20.Nakamura T, Murakami M, Horiguchi H, et al. A case of thymic enlargement in hyperthyroidism in a young woman. Thyroid 2004; 14:307–310. [DOI] [PubMed] [Google Scholar]
- 21.Niendorf ER, Parker JA, Yechoor V, et al. Thymic hyperplasia in thyroid cancer patients. J Thorac Imaging 2005; 20:1–4. [DOI] [PubMed] [Google Scholar]
- 22.Sehbai AS, Tallaksen RJ, Bennett J, et al. Thymic hyperplasia after adjuvant chemotherapy in breast cancer. J Thorac Imaging 2006; 21:43–46. [DOI] [PubMed] [Google Scholar]
- 23.Heath VL, Moore NC, Parnell SM, et al. Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun 1998; 11:309–318. [DOI] [PubMed] [Google Scholar]
- 24.Sospedra M, Ferrer-Francesch X, Domínguez O, et al. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J Immunol 1998; 161:5918–5929. [PubMed] [Google Scholar]
- 25.Gotter J, Brors B, Hergenhahn M, et al. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med 2004; 199:155–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Schneider J, Divgi C, Scott A, et al. Hiatal hernia on whole-body radioiodine survey mimicking metastatic thyroid cancer. Clin Nucl Med 1993; 18:751–753. [DOI] [PubMed] [Google Scholar]
